Provided by Tiger Trade Technology Pte. Ltd.

Camp4 Therapeutics Corp.

4.33
-0.1500-3.35%
Volume:33.64K
Turnover:148.28K
Market Cap:271.72M
PE:-1.95
High:4.52
Open:4.46
Low:4.26
Close:4.48
52wk High:7.75
52wk Low:1.41
Shares:62.75M
Float Shares:37.87M
Volume Ratio:0.22
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2250
EPS(LYR):-2.6500
ROE:-545.85%
ROA:-45.25%
PB:-392.09
PE(LYR):-1.63

Loading ...

Camp4 Therapeutics Corp - Eligible to Raise up to $50 Mln Through Second Closing of Private Placement

THOMSON REUTERS
·
Jul 27

Camp4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of Cmp-002 in Patients with Syngap1-Related Disorder

THOMSON REUTERS
·
Jul 27

Camp4 Therapeutics Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 18

Positive Report for CAMP4 Therapeutics Corporation (CAMP) from J.P. Morgan

TIPRANKS
·
Jun 23

Camp4 Therapeutics grants 39,000 inducement stock options at $3.96 per share

Reuters
·
Jun 20

Camp4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 20

Sector Update: Healthcare

MT Newswires Live
·
Jun 17

Discovr Radio to Embed Across All Four Days of CAMP Toronto in First Major Activation with Beatcave

GlobeNewswire
·
Jun 16

Camp4 Therapeutics upgraded to Overweight from Neutral at JPMorgan

TIPRANKS
·
Jun 16

U.S. RESEARCH ROUNDUP-CAMP4 Therapeutics, Rockwell Automation, Zions Bancorporation

Reuters
·
Jun 16

CAMP4 Shareholders Approve Equity Plan Changes and Inducement Plan

TIPRANKS
·
Jun 13

Camp4 Therapeutics shareholders approve amendment to 2024 equity incentive plan at annual meeting

Reuters
·
Jun 13

CAMP4 Therapeutics Initiated at Buy by Chardan Capital

Dow Jones
·
Jun 10

Chardan Initiates Camp4 Therapeutics at Buy With $6.50 Price Target

MT Newswires Live
·
Jun 10

Camp4 Therapeutics initiated with a Buy at Chardan

TIPRANKS
·
Jun 10

U.S. RESEARCH ROUNDUP- Datadog, Eli Lilly, Oracle

Reuters
·
Jun 10

CAMP4 Therapeutics Corporation (CAMP) Receives a New Rating from Chardan Capital

TIPRANKS
·
Jun 10

Camp4 Therapeutics Corp : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $6.5

THOMSON REUTERS
·
Jun 10

U.S. big tech holds 85% of Canadian cloud market, report says ahead of AI strategy

Bloomberg
·
Jun 02

Camp4 Therapeutics grants inducement option for 5,000 shares at $4.31 exercise price

Reuters
·
May 22